Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.15 GBX | +0.55% | -4.69% | -12.86% |
03-26 | Scancell doses first patient in melanoma-focused trials | AN |
03-22 | Seneca Growth Capital announces tepid 2023 results | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.86% | 94.15M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- SCLP Stock
- News Scancell Holdings plc
- Scancell : Selects COVID-19 Vaccine Candidate for Development, Clinical Trials